Astrana Health, Inc.
ASTH
$40.81
$3.027.99%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 212.44% | 258.44% | 117.43% | 73.12% | -39.99% |
| Total Other Revenue | 57.90% | 55.71% | 56.09% | 68.28% | 53.42% |
| Total Revenue | 58.91% | 56.69% | 56.39% | 68.17% | 51.97% |
| Cost of Revenue | 60.41% | 58.97% | 61.09% | 77.75% | 61.02% |
| Gross Profit | 47.11% | 39.88% | 25.85% | 14.27% | 5.43% |
| SG&A Expenses | 32.31% | 42.52% | 33.90% | 24.27% | 21.56% |
| Depreciation & Amortization | 116.26% | 83.22% | 63.82% | 51.70% | 34.03% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 59.04% | 58.11% | 58.97% | 72.44% | 56.88% |
| Operating Income | 54.65% | 18.91% | 0.10% | -14.39% | -25.09% |
| Income Before Tax | 17.04% | -25.15% | -50.99% | -63.89% | -45.86% |
| Income Tax Expenses | -11.94% | -30.97% | -49.72% | -21.34% | -16.04% |
| Earnings from Continuing Operations | 41.90% | -21.14% | -51.78% | -83.10% | -58.50% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 155.60% | 82.38% | 76.57% | -104.13% | -231.37% |
| Net Income | 60.53% | -13.64% | -47.89% | -84.73% | -63.08% |
| EBIT | 54.65% | 18.91% | 0.10% | -14.39% | -25.09% |
| EBITDA | 72.50% | 36.12% | 15.27% | 0.52% | -14.12% |
| EPS Basic | 59.88% | -15.33% | -49.20% | -85.75% | -64.34% |
| Normalized Basic EPS | 26.04% | -14.37% | -37.71% | -53.84% | -49.22% |
| EPS Diluted | 61.29% | -15.12% | -48.58% | -85.70% | -64.67% |
| Normalized Diluted EPS | 26.14% | -14.01% | -37.51% | -53.80% | -49.33% |
| Average Basic Shares Outstanding | 2.47% | 3.35% | 3.81% | 1.65% | 1.45% |
| Average Diluted Shares Outstanding | 2.57% | 3.20% | 3.72% | 1.42% | 1.45% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -0.76% | -0.34% | 170.11% | -0.32% | -0.73% |